Menu

FDA Recommends Kratom Byproduct to be Classified Alongside Illegal Drugs

On July 29, 2025, the U.S. Food and Drug Administration (FDA) announced plans to crack down on an opioid substance derived from the kratom plant known as 7-hydroxymitragynine (7-OH). FDA Commissioner Marty Makary said the agency is urging the Drug Enforcement Agency (DEA) to classify 7-OH as a Schedule 1 substance.

7-OH can be found in tablets, gummies and drink mixes commonly sold online, in gas stations and convenience stores. FDA officials said they are not targeting the herbal supplement kratom but products containing its byproduct sold in synthetic concentrations. The FDA has already issued warning letters to seven companies for illegal marketing products containing 7-OH. The products advertise the compound as an added ingredient, or being included at enhanced levels. Read more here.

About CDA

The Convenience Distribution Association (CDA) is the trade organization working on behalf of convenience products distributors in the United States. Its distributor members represent more than $102 billion in U.S convenience product sales, serving a wide variety of small retail formats. Associate members include leading convenience product manufacturers, brokers, retailers, suppliers and others allied to the industry.

footerlogo

Disclaimer

CDA does not endorse any product or service that is advertised in CDA magazines or newsletters, displayed at CDA trade shows, or otherwise promoted by CDA members. CDA has not verified whether any tobacco or deemed tobacco product is authorized pursuant to current FDA rules and regulations. CDA shall not be liable for any purchase of, use by, or claim relating to any advertised product.

Helpful Links

Contact Info

  •   Address:
    11250 Roger Bacon Drive #8,
    Reston, VA 20190
  •   Phone:
    (703) 208-3358
  •   Fax:
    (703) 573-5738